Metal Shards Found In THESE Pills

Capsules and a yellow warning sign
Photo: Teacher Photo / Shutterstock

A single lot of a widely used blood pressure pill is now off pharmacy shelves after tests pointed to possible metal fragments inside the capsules.

Quick Take

  • Breckenridge Pharmaceutical recalled one lot of propranolol hydrochloride extended-release capsules, 60 mg, over possible stainless-steel contamination.
  • The affected product is a 100-count bottle, lot PK25110035, with an expiration date of May 2029.
  • Officials warn the metal could cut the mouth, throat, stomach, or intestines if swallowed.
  • The pills shipped nationwide between late October and early November 2026.

What Triggered The Nationwide Recall

Breckenridge Pharmaceutical announced a voluntary nationwide recall on November 16, 2026, pulling one lot of its propranolol hydrochloride extended-release capsules. The company’s notice pointed to “potential metal contamination” as the reason for the action. Propranolol is a beta-blocker doctors prescribe to treat high blood pressure, irregular heartbeats, and other heart conditions, making this a drug many older Americans take every single day.

The California State Board of Pharmacy issued its own alert the next day, naming the metal as austenitic stainless steel, a type commonly used in manufacturing equipment. That detail matters because it tells patients and pharmacists exactly what to look for, rather than leaving the public guessing about a vague “contaminant.”

How Officials Traced The Problem Back To The Source

The state board’s alert explains the recalled lot shared the same intermediate material as a separate lot that never reached pharmacy shelves. That other lot showed signs of metal contamination during production, so regulators treated the marketed lot as a shared risk, even without confirming contamination in every bottle. This is standard practice in drug manufacturing, where federal rules require companies to act on cross-lot risk before proving every single capsule is bad.

The recalled bottles carry National Drug Code 51991-817-01 and lot number PK25110035, with a May 2029 expiration date. Records show the pills moved through the supply chain between October 26 and November 4, 2026, reaching wholesalers and pharmacies nationwide. Anyone holding a 60 mg propranolol bottle should check those exact numbers before assuming their own supply is unaffected.

Why The Health Risk Is Taken So Seriously

Officials describe a specific and unsettling danger. Swallowing a capsule containing metal fragments could cut soft tissue in the mouth, esophagus, stomach, or intestines. That is not a vague side-effect warning tacked onto fine print. It is a direct, physical injury risk serious enough to justify pulling product nationwide rather than waiting for confirmed harm.

Breckenridge instructed consumers to stop taking capsules from the affected lot right away and to call their doctor or pharmacist for replacement instructions. That is sound, practical advice. Patients managing blood pressure or heart rhythm problems should never just quit a prescription cold turkey without medical guidance, since stopping a beta-blocker abruptly carries its own risks.

A Familiar Pattern In Drug Manufacturing Oversight

Foreign-material recalls like this one are not rare in the pharmaceutical industry. Federal manufacturing guidance requires companies to keep written procedures for recalling an intermediate or active ingredient as soon as contamination is suspected, not after harm is proven. Regulators have pulled other products in recent years over similar concerns, including an injectable drug recalled for potential foreign material and a saline solution recalled over unwanted particles.

That track record shows this recall fits an established, cautious approach drugmakers are required to follow. Companies and regulators would rather pull a lot early on suspicion than wait and risk a patient getting hurt. For conservative-minded consumers who value personal responsibility and plain facts over panic, the takeaway is simple: check your bottle, call your pharmacist if the numbers match, and keep taking your medication as prescribed otherwise.

Breckenridge has not reported confirmed injuries tied to this lot, and the recall rests on a precautionary finding rather than a proven injury count. Patients with questions about their specific bottle should contact their pharmacy directly rather than relying on secondhand reports online.

Sources:

foxbusiness.com, prnewswire.com, pharmacy.ca.gov